{"id":"W2132196134","doi":"10.1186/1475-2840-13-26","title":"Residual macrovascular risk in 2013: what have we learned?","year":2014,"lang":"en","type":"review","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; Montreal Clinical Research Institute; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"H. Lundbeck A/S; Servier; Astellas Pharma; Novo Nordisk; International Atherosclerosis Society; Québec Consortium for Drug Discovery; Anthera; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Genentech; Valeant Pharmaceuticals International; Daiichi Sankyo Europe; Kowa Company; Halozyme; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Amgen; Pfizer","keywords":"Ezetimibe; Medicine; Residual risk; PCSK9; Metabolic syndrome; Internal medicine; Statin; Niacin; Type 2 diabetes; Diabetes mellitus; Endocrinology; Intensive care medicine; Cholesterol; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.007989009,0.001607262,0.01547094,0.001305124,0.0002160663,0.000163271,0.0007900544,0.002770606,0.0001656154],"category_scores_gemma":[0.0006770372,0.001361729,0.01610921,0.0009566196,0.0004504876,0.0002830645,0.0004700617,0.003541132,0.001300988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006973044,"about_ca_system_score_gemma":0.00114554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005624708,"about_ca_topic_score_gemma":0.0001656714,"domain_scores_codex":[0.986239,0.00525531,0.002095964,0.002657064,0.001757832,0.00199483],"domain_scores_gemma":[0.9915558,0.0003444516,0.0006025648,0.006494682,0.0002732075,0.0007293148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002042472,0.0001050885,0.0001262529,0.02742445,0.01551775,0.001120927,0.00007138397,0.00005633346,4.63854e-8,0.00004677698,0.001433278,0.9540773],"study_design_scores_gemma":[0.003052695,0.0001575983,0.00009709209,0.01716,0.02029752,0.002163061,0.0001196476,0.00001708559,0.000002743912,0.0001080476,0.9556832,0.001141295],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001047643,0.9924113,0.0006144089,0.000321332,0.001368299,0.004257819,0.00004502122,0.0002071955,0.0006698432],"genre_scores_gemma":[0.0000430386,0.9942719,0.0004251722,0.0001707849,0.002536117,0.001062975,0.0006406831,0.0004345415,0.0004148106],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9542499,"threshold_uncertainty_score":0.9996675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03707531681915845,"score_gpt":0.3160759821856446,"score_spread":0.2790006653664862,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}